CymaBay Therapeutics Presents Positive Final Results From 52-Week Phase 2 Study in Primary Biliary Cholangitis at The Digital ...
Sustained anti-cholestatic and hepatoprotective effects observed in patients with and without cirrhosis Self-reported pruritus improved at one year for patients in highest categories of baseline itch Selected for inclusion in the “Best of ILC” presentation …